Michel Gréco

Chairman of the Board

 

Michel Gréco was appointed Chairman of GlycoVaxyn's Board in July 2007. He has over 35 years of experience in the pharmaceuticals industry, with an emphasis on vaccines. Most recently, he served, first as President and Chief Operating Officer, and later as deputy CEO, at Aventis Pasteur, until 2003. From 1994 to 1998, he helped establish and also served as President and Chief Executive Officer of Pasteur Merieux MSD, a joint venture between Merck & Co and Pasteur Merieux Connaught. Mr. Gréco has served as President of the European Vaccine Manufacturers, Chairman of the IFPMA's (International Federation of Pharmaceutical Manufacturers & Associations) biological group and as a member of the World Health Organization's Strategic Advisory Group of Experts. He also serves on the board of directors of Vivalis (France), is Chairman of Intercell (Austria) and is a member of the board of several private companies as well as of international non-profit institutions.

Mr. Gréco received a Master's degree from the Institut d'Etudes Politiques de Paris and an MBA from the Richard Ivey School of Business Administration at the University of Western Ontario.